Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
AssigneeAllergan, Inc.
InventorsEster Fernandez-Salas, Lance E. Steward, Kei Roger Aoki
Life of this patent
Estimating the term…
Loading patent…
AssigneeAllergan, Inc.
InventorsEster Fernandez-Salas, Lance E. Steward, Kei Roger Aoki
Estimating the term…
The present invention provides a method of determining clostridial toxin activity by (a) contacting with a sample a cell containing a clostridial toxin substrate that includes a donor fluorophore; an acceptor having an absorbance spectrum overlapping the emission spectrum of the donor fluorophore; and a clostridial toxin recognition sequence containing a cleavage site that intervenes between the donor fluorophore and the acceptor, where resonance energy transfer is exhibited between the donor fluorophore and the acceptor under the appropriate conditions; (b) exciting the donor fluorophore; and (c) determining resonance energy transfer of the contacted cell relative to a control cell, where a difference in resonance energy transfer of the contacted cell as compared to the control cell is indicative of clostridial toxin activity.
A method of determining clostridial toxin activity, comprising the steps of:
Dependencies are inferred from the claim text.